← Azimuth Daily
Capturing data…
Capturing data…
THU, 22 OCT · 89 ITEMS
"Moderna to release Phase 3 cancer vaccine results this weekend" — MarketWatch (Top Stories) · Science & Medicine
This refers to Moderna's personalized mRNA (mRNA-4157/V940, developed with Merck) for melanoma. Positive topline results from the INTerpath-001 trial were already announced in August 2026. This weekend, researchers will present the full detailed dataset at a medical conference — the first public airing of the complete efficacy and safety data, which carries major commercial and scientific implications for Moderna.
The claim is solid: MarketWatch, a reputable financial news outlet, reports the upcoming presentation, which is confirmed by multiple other outlets (Morningstar, Pluang) and aligned with the previously announced topline results. The underlying primary source will be the conference presentation and any simultaneous publication.
Genuinely new — this reports on a planned release for the upcoming weekend (October 24, 2026), published on October 21, 2026.